(Q55463256)

English

Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.

scientific article published on 8 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

0 references

1 reference

based on heuristic

inferred from title

9

object named as

Kenji Wakai

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

author name string

Kazuya Motomura

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Atsushi Natsume

2

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Yugo Kishida

3

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Hiroyuki Higashi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Yutaka Kondo

5

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Yoko Nakasu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Tatsuya Abe

7

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Hiroki Namba

8

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Toshihiko Wakabayashi

10

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

language of work or name

0 references

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

117

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

8

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

1721-1730

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Mutant metabolic enzymes are at the origin of gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

The DNA demethylating agent 5-aza-2'-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Genetic pathways to glioblastoma: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

TP53 Cancerous Mutations Exhibit Selection for Translation Efficiency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Interferons at age 50: past, current and future impact on biomedicine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

21 January 2018

Multiplex ligation-dependent probe amplification (MLPA) screening in meningioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

7 January 2021

based on heuristic

inferred from DOI database lookup

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25637

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25637

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/21472719

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55463256&oldid=1773405285"